BACKGROUND: Liquid biopsy provides important information for the prognosis and treatment of cancer patients. In this study, we evaluated the effects of preanalytical conditions on gene expression and DNA methylation analyses in liquid biopsies.
Liquid biopsy provides noninvasive real-time monitoring of tumor evolution and therapeutic efficacy for cancer patients, and has received enormous attention because of its obvious clinical implications for personalized medicine (1 ) . Circulating tumor cell (CTC) 2 analysis offers a unique tool to provide deeper understanding of metastasis biology and therapy resistance (2 ) , whereas circulating tumor DNA (ctDNA) analysis enables the identification of genomic alterations, treatment response, and early detection of disease progression (3, 4 ) . Moreover, DNA methylation analysis in CTCs and ctDNA has strong potential to provide another valuable source of circulating epigenetic biomarkers (5, 6 ) . We were the first to report epigenetic changes in CTCs (7, 8 ) and demonstrated a close correlation between DNA methylation in primary tumors, CTCs, and paired plasma ctDNA (8 -10 ) . The molecular characterization of CTCs at the DNA, RNA, and protein level is challenging because these cells are extremely fragile and rare, and the amount of available sample is limited (2 ) .
However, despite all the important information that liquid biopsy can provide, it has not been implemented yet into routine clinical practice. Standardization of the procedures used at both the preanalytical and analytical levels is important to achieve this goal (1, 2 ) . Preanalytical conditions such as delays in blood processing, storage temperature of peripheral blood (PB), and even agitation of the sample during shipment of blood can affect the integrity of highly fragile CTCs, and control of these conditions is essential for reliable downstream CTC anal-ysis (11, 12 ) . Lack of such control could potentially explain many discrepancies reported in the literature (13 ) . Because CTC-mRNA is extremely fragile, gene expression studies in CTCs may be affected by a variety of factors. One important preanalytical factor is the time interval between PB draw and CTC isolation, as the preservatives used in PB collection tubes can severely affect the stability of CTC-mRNA. However, the effect of preanalytical parameters on gene expression in CTCs has not been studied in detail so far. Numerous studies have already evaluated parameters potentially affecting ctDNA concentration and fragmentation and have described the optimal preanalytical handling conditions for ctDNA analysis (4, (13) (14) (15) (16) (17) (18) (19) (20) . However, the effects of preanalytical parameters on DNA methylation analysis in liquid biopsy have not been studied yet.
The aim of our study was to evaluate in detail (a) the effect of preanalytical conditions on gene expression analysis in CTCs, (b) the stability of DNA methylation in plasma, (c) the stability of sodium bisulfite (SB)converted DNA samples under different storage conditions, and (d) the accuracy and precision of whole genome amplification (WGA) protocols for downstream DNA methylation analysis. We present for the first time a quality control procedure to ensure the reliability of gene expression and DNA methylation analysis in liquid biopsies.
Materials and Methods

RNA-BASED CTC ANALYSIS
Preparation of spiked PB samples. PB samples collected from healthy donors were drawn into 6 different types of tubes in triplicate (10 mL): (a) K 2 EDTA (BD Vacutainer), (b) cell-free RNA (cfRNA) blood collection tube (BCT)(Streck), (c) cell-free DNA (cfDNA) BCT (Streck), (d) BD/ACD-A in combination with Adnatubes (Qiagen), (e) Cellsave (Menarini-Silicon Biosystems), and (f) Transfix (Cytomark). In all cases, the first 5 mL of blood was discarded to avoid skin epithelial cell contamination. In each tube, MCF-7 cells (100 cells enumerated in a Malassez hemocytometer) were spiked into PB (10 mL), mixed immediately after spiking by inverting gently 10 times, and then stored at room temperature. Samples were further processed at 3 different time points: (a) immediately (T 0 ), (b) after 24 h (T 24 ), and (c) after 48 h (T 48 ).
CTC enrichment. After adding 30 mL of red cell lysis buffer (containing NH 4 Cl, 155 mmol/L; KHCO 3 , 10 mmol/L; and EDTA, 0.1 mmol/L, pH ϭ 7.3), samples were incubated (20 min) at room temperature, mixing occasionally by gentle inversion; after centrifugation (530g, room temperature, 20 min), the supernatant was removed and subsequently red cell lysis buffer (30 mL) was added. After a second centrifugation (530g, room temperature,10 min), the supernatant was removed and red cell lysis buffer (10 mL) was added. Capture beads, coated with the monoclonal antibody BerEP4 against the human epithelial antigen EpCAM (Dynabeads ® Epithelial Enrich, Life Technologies), were further used for CTC enrichment (21 ) .
RNA extraction, cDNA synthesis, and RT-qualitative PCR. Total RNA was isolated from the EpCAM-positive CTC fraction using TRIZOL-LS (ThermoFisher), and cDNA synthesis was performed as previously described (21 ) . Total RNA concentration was measured in a NanoDrop-1000 spectrophotometer, calibrated with the recommended CF-1 standard solution. Total RNA (100 ng/L) isolated from MCF-7 cells was used as a positive control for cDNA synthesis. For gene expression, we used our previously developed and analytically validated RT-qualitative PCR (qPCR) assays for B2M 3 and CK19 (21, 22 ) .
DNA METHYLATION ANALYSIS IN LIQUID BIOPSY
ctDNA isolation from plasma. PB was collected from 2 healthy donors into 10-mL K 2 EDTA tubes. Plasma was isolated within 2 h from PB by centrifugation (530g, room temperature, 10 min). Once isolated, plasma samples were centrifuged again (2000g, room temperature, 10 min) and pooled before transferring into clean 2-mL tubes. Plasma samples were maintained at room temperature until spiking. Genomic DNA (gDNA) was isolated from MCF-7 and SKBR3 (10 6 cells) using the QIAamp DNA Micro Kit (Qiagen) and dissolved in 30 L of Tris-EDTA buffer (10 mM Tris-HCl, 0.1 mM EDTA, pH ϭ 8) (ThermoFisher). DNA concentration was measured in a NanoDrop-1000 spectrophotometer and calibrated with the recommended CF-1 standard solution. DNA (1000 ng) from MCF-7 cells was sonicated for 30 min and subsequently spiked into 4 tubes containing 2 mL of pooled plasma. Each tube was stored at Ϫ80°C and further analyzed at T 0 : 0 days, T 1 : 1 months, T 3 : 3 months, and T 8 : 8 months. The QIAamp Circulating Nucleic Acid Kit (Qiagen) was used to isolate ctDNA from 2 mL of plasma. SB conversion. ctDNA isolated from spiked plasma samples and gDNA isolated directly from MCF-7 and SKBR3 cells were accordingly SB-converted. For the stability study of DNA methylation in plasma and SBconverted DNA samples under different storage conditions, we used the EZ-DNA Methylation Gold Kit (ZYMO Research). SB-converted DNA from MCF-7 (spiked in plasma) was stored at Ϫ80°C until use, whereas SB-converted DNA from SKBR3 was stored in aliquots at Ϫ20°C and Ϫ80°C. For downstream WGA studies, we also used the EpiTect Fast Bisulfite Kit (Qiagen); the bisulfite reaction volume was set up for both high (1 ng to 2 g) and low (1-500 ng) DNA concentrations, according to manufacturer's instructions, and the eluted placental and 100% methylated SB-converted DNA standards were stored at Ϫ80°C.
WGA. WGA of SB-converted DNA was performed using the EpiTect Whole-Bisulfitome Kit (Qiagen). This protocol is optimized for the amplification of Ͼ50 ng of SB-converted DNA, diluted with nuclease-free water to a final volume of 10 L. The amplification was performed in a thermal cycler (Mastercycler ® pro, Eppendorf) (28°C/8 h, 95°C/5 min, and 4°C until storage; lid temperature set to 70°C). After WGA, SB-converted DNA was diluted (1:10 and 1:5) for further downstream realtime methylation-specific PCR (MSP) analysis.
Real-time MSP. The quality of SB-converted DNA was first checked by real-time MSP for ␤-actin (ACTB), and then our previously described real-time MSP for SOX17 and BRMS1 (10 ) was used for downstream evaluation of SB-converted DNA stability and WGA performance. The stability of DNA methylation in plasma was evaluated using real-time MSP for SOX17, whereas the stability of SB-converted DNA was evaluated using real-time MSP for BRMS1. WGA performance for SB-converted DNA was evaluated using real-time MSP for SOX17. Human placental gDNA (Sigma-Aldrich) was used as control after SB conversion. Universal Methylated Human DNA Standard (ZYMO Research) was used as fully methylated positive control.
STATISTICAL ANALYSIS
Statistical analysis was performed using SPSS statistics version 23. A P value Յ0.05 was considered significant. Graphics were generated with MS Excel 2010 (Microsoft), and Levey-Jennings graphs were created with QI Macros: SPC Software for Excel (KnowWare International).
Results
RNA-BASED CTC ANALYSIS
Quality control. Systematic quality control was performed for all steps involved in the procedure to ensure the quality and reproducibility of results ( Fig. 1 ). Positive controls were used for monitoring assay variation over time according to the Minimum Information for Publication of Quantitative Real-Time PCR Experiments guidelines (23 ) . The specific steps follow. cDNA synthesis step. In each cDNA synthesis experiment, we included a cDNA synthesis control. For this purpose, we aliquoted in 23 different vials 100 ng/L of MCF-7 RNA and stored them at Ϫ80°C. From the Levey-Jennings graph ( Fig. 2A , part 2) derived using the B2M assay, 19 of 23 (82.6%) Cq values were within Ϯ1 SD of the mean value, whereas 3 of 23 values were within Ϯ2 SD and 1 was within Ϯ3 SD. For the positive control of cDNA synthesis, using the CK19 assay, 19 of 23 (82.6%) Cq values were within Ϯ1 SD, whereas 3 of 23 values were within Ϯ2 SD. In 1 case (day 134), the Cq value exceeded the control limit, indicating a control random error; thus, the relationship between this value and the other results within the current and previous assays was examined. Because the Cq value of the RNAextraction control, analyzed on the same day, was within the limit of Ϯ2 SD from the mean value, the final result was accepted.
RT-qPCR step. To evaluate the accuracy and reproducibility of RT-qPCR in each RT-qPCR run, we included in all runs the same cDNA as a positive control. For this purpose, we aliquoted cDNA from MCF-7 cells and then stored these 23 different aliquots at Ϫ80°C. According to Levey-Jennings graphs ( Fig. 2A, part 3) , none of the quality control criteria was violated.
Stability of CTC-mRNA. We evaluated the effect of type of BCTs and storage conditions on the stability of CTC-mRNA for downstream gene expression studies (Fig. 3) . When PB was stored in K 2 EDTA tubes, CK19 mRNA was readily detectable at all time points (T 0 , T 24 , and T 48 ). In cfDNA BCT tubes, CK19 mRNA was detected at all time points but at a higher Cq, indicating a significant degradation of CTC-mRNA in these tubes. In ACD-A/Adnatubes, CK19 mRNA was detected at T 0 and T 48 ; however, at T 48 , far fewer copies were observed. In cfRNA BCT, Cellsave, and Transfix tubes, CK19 mRNA was detected only at T 0 but not at T 24 or T 48 , indicating a significant degradation of CTC-mRNA in these tubes. B2M expression was significantly lower in cfRNA BCT, Cellsave, and Transfix tubes when compared with K 2 EDTA tubes at all time points. Our data suggest that CTC-mRNA analysis is severely affected by the preservatives used in these tubes (Fig. 4, A and B) .
Recovery rates at all time points were estimated by comparing our results with those obtained using MCF-7 cells analyzed the same way but not subjected to the PB spiking and downstream isolation steps. For this purpose, 10, 100, 1000, and 10000 MCF-7 cells were lysed at T 0 and processed to mRNA isolation, cDNA synthesis, and RT-qPCR using identical protocols. A calibration curve based on CK19 RT-qPCR for a known number of MCF-7 cells run in triplicate for each concentration (Fig.  4C) was used for the estimation of the percentage recovery in each PB collection tube at 3 specific time points (T 0 , T 24 , and T 48 ) (see Table 1 in the Data Supplement that accompanies the online version of this article at http://www.clinchem.org/content/vol64/issue10). The mean recovery at T 0 was 86% in K 2 EDTA, 50% in cfDNA BCT, 32% in cfRNA BCT, 107% in ACD-A/ Adnatubes, 11% in CellSave, and 15% in Transfix tubes (Fig. 4D) . At T 24 , the mean recovery was 44% in K 2 EDTA and 9% in cfDNA BCT tubes. At T 48 , the mean recovery was 36% in K 2 EDTA and 6% in ACD-A/Adnatubes.
DNA METHYLATION ANALYSIS IN LIQUID BIOPSY
Quality control. Positive and negative controls were included in all steps to ensure the quality and reproducibility of results ( Fig. 1 ). SB-conversion step. We evaluated the accuracy and reproducibility of the whole procedure over time and during different time points and different runs of SB conversion of DNA samples by including 100% methylated, SKBR3, and MCF-7 SB-converted DNA as positive controls and creating Levey-Jennings graphs. As can be seen in Fig. 2B , parts 1 through 3, none of the quality control criteria was violated.
Real-time MSP. To establish a quality control procedure for each analytical run, we created a Levey-Jennings graph including all positive controls used in real-time MSP assays. For the 100% methylated positive control, approximately all Cq values fall within Ϯ1 SD, indicating that the analytical process is within control. When SB-converted DNA from MCF-7 cells was used as a control, 66.7% of total Cq values were within Ϯ1 SD, whereas 2 values were within Ϯ2 SD of the mean value, pointing out a process within control limits. Finally, when SB-converted DNA from SKBR3 cells was used as a control, none of the Westgard rules was violated, as 83.3% of Cq values were within Ϯ1 SD and 1 value was within Ϯ2 SD ( Fig. 2B, parts 4 -6) .
Stability of DNA methylation in plasma. Plasma spiked with MCF-7 DNA was separated in 4 aliquots and further used to evaluate the stability of DNA methylation during storage. One aliquot was immediately processed (T 0 ), whereas the remaining 3 aliquots were stored at Ϫ80°C and analyzed at 3 different time points (T 1 , T 3 , T 8 ) in a total period of 8 months (Fig. 5A) . Each sample was analyzed in triplicate, and the average Cq (mean Ϯ SD) values over time are presented in Fig. 5B . When performing a 2-tailed paired t-test between Cq values at day 0 and each different time point, our results indicate that plasma storage at Ϫ80°C for a period of up to 3 months does not significantly affect ctDNA methylation analysis; however, for both genes tested, we observed a statistically significant differentiation (P Ͻ 0.05) when plasma was stored for 8 months.
Stability of SB-converted DNA. We further evaluated the stability of SB-converted DNA over time. gDNA was isolated from 10 6 SKBR3 cells, SB-converted, split into 12 aliquots, and stored at Ϫ20°C and Ϫ80°C. Single aliquots were defrosted at different time points (T 0 , T 1 , T 3 , T 6 , T 12 ) for a total period of 1 year, and the stability of SB-converted DNA was evaluated by real-time MSP for ACTB and BRMS1. The effect of multiple freezethaw cycles on Cq differences was assessed in parallel by analyzing 1 SB-converted DNA sample that was defrosted in each time point (Fig. 6A) . Each sample was analyzed in triplicate, and the Cq (mean Ϯ SD) values are shown in Fig. 6B . After performing a 2-tailed paired t-test between Cq values at day 0 and at each different time point, we conclude that SB-converted DNA is stable under storage at Ϫ20°C and Ϫ80°C for up to 1 year. Moreover, repetitive freeze-thaw steps do not affect stability of SBconverted DNA. Thus, SB-converted DNA samples stored at either Ϫ20°C or Ϫ80°C can be used safely for downstream molecular analysis using real-time MSP assays.
Combination of SB conversion with downstream WGA.
We further compared the efficacy of 2 different SB- conversion kits (EpiTect Fast Bisulfite Kit and EZ-DNA Methylation Gold Kit), in combination with downstream WGA using the EpiTect Whole-Bisulfitome Kit (Qiagen) that is specifically designed for real-time MSP applications. When the EpiTect Fast Bisulfite Kit was used, best results were obtained when setting the SB conversion for high concentration samples and diluting the SB-converted and amplified DNA 1:10 before MSP. 
Liquid Biopsy: QC and Preanalytical Aspects
Real-time MSP results before and after amplification, both for placental DNA and 100% methylated DNA, were similar only when samples were diluted 1:10 and used as a target for real-time MSP. In every other case, discrepancies were observed. When the EZ-DNA Methylation Gold Kit was combined downstream with the EpiTect Whole-Bisulfitome Kit, our results revealed that samples should not be diluted for MSP after the amplification reaction because it was only in this case that Cq values before and after amplification were almost the same. In contrast, when amplified SB-converted samples were diluted (1:5 or 1:10), a significant loss in WGA performance was observed (see Table 2 in the online Data Supplement). 
Discussion
Liquid biopsy is based on the analysis of CTCs, ctDNA, circulating microRNA, and tumor-derived extracellular vesicles (1, 2, 24, 25 ) . ctDNA and CTCs have complementary roles as a source of cancer biomarkers in liquid biopsy (1, 2 ) . RNA-based CTC analysis can elucidate the critical signaling pathways involved in cancer biology (1, 26 ) and give important prognostic and predictive information, as studies on CK19 (21, 22 ) , PD-L1 (27 ) , and AR-V7 have shown (28 ) , whereas ctDNA analysis can be applied as a high-throughput strategy for the assessment of clinical samples, but is limited to point mutations, structural rearrangements, copy number aberrations, and changes in DNA methylation.
Clinical utility of liquid biopsy tests can be evaluated only when based on standardized and strictly controlled procedures. Preanalytical factors, if not properly recognized and controlled, can have a serious effect on sample quality and, thus, on the quality of liquid biopsy analyses. Lack of standard operating procedures is severely impeding the application of CTC-based and ctDNA-based diagnostic tests in the clinic (29 ) . Molecular analysis of CTCs has been limited by the requirement to process fresh blood within a few hours after blood draw (30, 31 ) . To minimize preanalytical errors because of the stability of CTCs in PB during transportation to distant sites, a variety of tubes based on the addition of specific preservatives intended to extend the time between blood draw and CTC isolation has been proposed. Commercially available cfDNA BCTs are claimed to stabilize nucleated blood cells, preventing the release of cellular DNA into plasma and inhibiting degradation of cfDNA (14 -16 ) . However, most of these tubes are designed for a downstream analysis of CTCs at the protein level based on imaging approaches, but not for gene expression studies.
In the present study, we first evaluated the effect of preanalytical conditions for gene expression analysis in CTCs. Our data indicate that RNA-based CTC analysis is severely impeded by the preservatives used in most tested PB collection tubes, except when common K 2 EDTA tubes are used and analysis is completed within 24 h and, at most, 48 h. Our results are in full agreement with those previously reported for AR-V7 quantification by droplet digital PCR in CTCs (32 ) . cfDNA BCTs were proposed for CTC analysis in a study using highdefinition single-cell analysis (12 ) and in another study using CellSearch (33 ) . However, when we evaluated these cfDNA BCTs for gene expression in CTCs, CK19 mRNA was detected at all time points but at higher Cq numbers than in K 2 EDTA, indicating a significant degradation of mRNA transcripts. The discrepancies between our results and the studies above may be attributed primarily to the different approaches used for detection of CTCs: RNA-based in our case vs enumeration of CTCs and protein-based CTC imaging, respectively (12, 33 ) . When using cfRNA BCTs, we found that CK19 mRNA was detected only at T 0 but not at T 24 and T 48 , whereas B2M expression was significantly lower when compared with K 2 EDTA tubes at all time points. In Cellsave tubes, we detected CK19 mRNA only at T 0 but not at T 24 and T 48 , indicating a significant degradation of CTC-mRNA, whereas B2M expression was also significantly lower than in K 2 EDTA tubes at all time points. TransFix tubes have been used to detect CTCs by image analytics after fluorescence scanning microscopy (34 ) ; however, according to our results, they are not appropriate for RNA-based studies. When we evaluated CTC-mRNA stability in ACD-A/Adnatubes, CK19 mRNA was detected at T 0 and T 48 ; however, at T 48 , far fewer copies were observed for both CK19 and B2M.
We further evaluated the effect of preanalytical conditions on DNA methylation analyses in liquid biopsies, such as the time interval to plasma isolation, storage conditions for SB-converted DNA, and the validity of WGA for SB-converted DNA. Adverse results on the stability of DNA methylation during different storage conditions of whole blood over time have been reported; according to 1 study, storage conditions have no impact on DNA integrity and methylation (35 ) , whereas a significant increase in methylation after 10 months of whole blood storage was reported in another study (36 ) . Our results indicate that DNA methylation information is not preserved when ctDNA extraction is performed in plasma stored for 8 months even at Ϫ80°C. On the contrary, SBconverted DNA can be safely stored before DNA methylation analysis by real-time MSP for 1 year at both Ϫ20°C and Ϫ80°C. When commercially available SBconversion kits were evaluated, the results varied from study to study (37) (38) (39) . Our results on the comparison of the efficacy of 2 SB-conversion kits, selected as the best among 12 different SB-conversion kits (37 ), showed similar values, with a slightly better performance for the EZ-DNA Methylation Gold Kit.
We evaluated for the first time the performance of WGA for DNA methylation studies in liquid biopsy, as this procedure can provide a large amount of DNA for downstream analysis. However, using conventional WGA, DNA methylation information is lost, unless unbiased amplification of SB-converted DNA is achieved (40 ) . Our proposed protocol ensures reliable WGA of SB-converted DNA; addition of this step could compensate for the limited amount of available sample for DNA methylation studies in liquid biopsies.
In the present study, we evaluated the effect of preanalytical parameters on gene expression in CTCs and on the stability of DNA methylation in plasma and SBconverted DNA under different storage conditions. According to our results, standardization of preanalytical parameters involved in gene expression and DNA methylation analysis is critical to ensure the reliability of results before any clinical application in liquid biopsy, for which the amount of available DNA is limited. Quality control checking should be included in each step of the analysis.
